CDMO News
Made Scientific Partners with Sentinel BioTherapeutics to Manufacture SENT-001 Cell Therapy
Made Scientific, a U.S.-based cell therapy CDMO, has announced a strategic partnership with Sentinel BioTherapeutics, a clinical-stage biotechnology company, to support the development of SENT-001, an encapsulated cell-based immunotherapy targeting solid tumours. The agreement focuses on SENT-001, a genetically engineered,
16 July 2025